Suchergebnisse - "Wingeyer, Silvia Perés"

PubPharm (13)

1

Loss of opportunities in the diagnosis and treatment of primary obstetric antiphospholipid syndrome (POAPS) : from theory to reality

enthalten in: Clinical rheumatology | 2024

von Udry, S. | Latino, J. | Perez, S. | +7

2

Loss of opportunities in the diagnosis and treatment of primary obstetric antiphospholipid syndrome (POAPS): from theory to reality

enthalten in: Clinical rheumatology | 2024

von Udry, S. | Latino, J. | Perez, S. | +7

3

Clinical and therapeutic value of the adjusted Global Antiphospholipid Syndrome Score in primary obstetric antiphospholipid syndrome

enthalten in: Lupus | 2022

von Udry, S. | Peréz, S. | Belizna, C. | +7

4

Risk factors for early severe preeclampsia in obstetric antiphospholipid syndrome with conventional treatment. The impact of hydroxychloroquine

enthalten in: Lupus | 2020

von Latino, J. | Udry, S. | Aranda, F. | +4

5

What is the best time to assess the antiphospholipid antibodies (aPL) profile to better predict the obstetric outcome in antiphospholipid syndrome (APS) patients?

enthalten in: Immunologic research | 2018

von Latino, J. | Udry, S. | Wingeyer, S. | +3

6

What is the best time to assess the antiphospholipid antibodies (aPL) profile to better predict the obstetric outcome in antiphospholipid syndrome (APS) patients?

enthalten in: Immunologic research | 2018

von Latino, J. | Udry, S. | Wingeyer, S. | +3

7

What is the best time to assess the antiphospholipid antibodies (aPL) profile to better predict the obstetric outcome in antiphospholipid syndrome (APS) patients?

enthalten in: Immunologic research | 2018

von Latino, J. | Udry, S. | Wingeyer, S. | +3

8

What is the best time to assess the antiphospholipid antibodies (aPL) profile to better predict the obstetric outcome in antiphospholipid syndrome (APS) patients?

enthalten in: Immunologic research | 2018

von Latino, J. | Udry, S. | Wingeyer, S. | +3

9

The -2518 A/G polymorphism in the monocyte chemoattractant protein 1 gene is associated with the risk of developing systemic lupus erythematosus in Argentinean patients : a multicenter study

enthalten in: European cytokine network | 2012

von Aranda, F. | Wingeyer, S. | Muñoz, S. | +10

10

Role of 4G/5G promoter polymorphism of Plasminogen Activator Inhibitor-1 (PAI-1) gene in outcome of sepsis

enthalten in: Thrombosis research | 2010

von Wingeyer, S. | de Larrañaga, G. | Cunto, E. | +3